Daniel Cherry
Papers
1
Total Citations
5
H-Index
1
About
Dr. Daniel Cherry is a leading surgical oncologist whose research focuses on the treatment of human papillomavirus-positive oropharyngeal squamous cell carcinoma (HPV-OPC), with a particular emphasis on transoral robotic surgery (TORS) outcomes. His major contribution lies in challenging the generalizability of TORS data, which has historically been derived from high-volume tertiary-care centers. By analyzing long-term recurrence and survival outcomes within the unique, multi-site Veterans Health Administration system, his landmark 2023 study provides critical real-world evidence on the effectiveness of this minimally invasive approach. This work, which has garnered early attention with 5 citations, is vital for understanding how patient demographics and healthcare delivery models influence oncologic results. Dr. Cherry’s research is instrumental in bridging the gap between specialized academic findings and broader clinical practice, ensuring that treatment guidelines for HPV-OPC are robust and applicable across diverse patient populations. His dedication to improving surgical outcomes for veterans underscores a commitment to both clinical excellence and health equity.
Research Focus
Key Achievements
Top Papers
- 1